Cash Flow Statement
Growth Metrics

Elevance Health (ELV) Debt to Equity (2016 - 2025)

Elevance Health (ELV) has disclosed Debt to Equity for 17 consecutive years, with $0.7 as the latest value for Q4 2025.

  • Quarterly Debt to Equity fell 5.91% to $0.7 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.7 through Dec 2025, down 5.91% year-over-year, with the annual reading at $0.7 for FY2025, 5.91% down from the prior year.
  • Debt to Equity for Q4 2025 was $0.7 at Elevance Health, down from $0.71 in the prior quarter.
  • The five-year high for Debt to Equity was $0.75 in Q4 2024, with the low at $0.56 in Q1 2022.
  • Average Debt to Equity over 5 years is $0.64, with a median of $0.65 recorded in 2022.
  • The sharpest move saw Debt to Equity fell 18.39% in 2022, then increased 25.43% in 2024.
  • Over 5 years, Debt to Equity stood at $0.59 in 2021, then rose by 10.7% to $0.66 in 2022, then dropped by 9.26% to $0.6 in 2023, then rose by 25.43% to $0.75 in 2024, then dropped by 5.91% to $0.7 in 2025.
  • According to Business Quant data, Debt to Equity over the past three periods came in at $0.7, $0.71, and $0.68 for Q4 2025, Q3 2025, and Q2 2025 respectively.